N

NATCO Pharma
NATCOPHARM

Last Price

Financial Snapshot

gainify

Market Data

Market Cap
₹154.45B
EV
₹132.33B
Shares Outstanding
179.11M
Beta
0.34

Wall Street View

Analyst Rating
HOLD
Analyst Target Price
₹1047.00
P/E 2025E
8.11x
P/Revenue 2025E
3.44x

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About NATCO Pharma Limited

gainify

N

NATCO Pharma Limited

NATCOPHARM

NATCO Pharma Limited, a pharmaceutical company, engages in the developing, manufacturing, and marketing of finished dosage formulations, active pharmaceutical ingredients (APIs), and intermediates in India, the United States, and internationally. It offers formulation...

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

CEO

Nannapaneni, Rajeev

Employees

4,016

IPO Date

1996-01-01

Headquarters

Natco House, Road No. 2, Banjara Hills, Hyderabad 500034, India

gainify
Send us an emailFollow us on XConnect with us on LinkedInFollow us on InstagramFollow us on Threads
powered-by-sp

Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2025, S&P Global Market Intelligence. All rights reserved.

View Data Providers

NEWSLETTER

Gainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.

© 2025 Gainify. All rights reserved.